Catabasis Pharmaceuticals
Why Robinhood?
You can watch CATB and buy or sell other stocks, ETFs, and their options commission-free!About CATB
Catabasis Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of novel therapeutics. Its lead product candidate is edasalonexent, which is intended for the treatment of Duchenne muscular dystrophy.
CATB Key Statistics
Stock Snapshot
The current Catabasis Pharmaceuticals(CATB) stock price is $14.47, with a market capitalization of 1.13B.
On 2026-06-09, Catabasis Pharmaceuticals(CATB) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Catabasis Pharmaceuticals(CATB) stock has reached 0, versus its average volume of 508.7K.
The stock's 52-week range extends from a low of $1.20 to a high of $8.59.
The stock's 52-week range extends from a low of $1.20 to a high of $8.59.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.